Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01015976 · ClinicalTrials.gov registry record · Phase 3
A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects
A Phase 3 study, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01015976: Completed Phase 3 study, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
NCT01015976 is a Phase 3 study that has completed, run by Neuropsychiatric Research Institute, Fargo, North Dakota. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01015976, a Phase 3 study, has completed, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the difference, if any, in the area under the sertraline plasma level time curve (AUC) between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Primary Outcome
AUC of surgery group compared to the AUC of control group
Interventions
- OTHER control
- PROCEDURE bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-04 |
| Phase | Phase 3 |
What the finished NCT01015976 record still lists
NCT01015976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which control is the first listed.
NCT01015976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01015976 about?
NCT01015976 is a clinical study titled "A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects". The purpose of this study is to determine the difference, if any, in the area under the sertraline plasma level time curve (AUC) between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
What is the current status of trial NCT01015976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2009-02. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01015976?
The interventions under investigation include: control (OTHER), bariatric surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01015976?
This trial is sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01015976's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia